Viewing Study NCT06163092


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-25 @ 1:57 PM
Study NCT ID: NCT06163092
Status: RECRUITING
Last Update Posted: 2025-03-20
First Post: 2023-11-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chronic Endometritis and Benefits of Antibiotics in Women With Recurrent Miscarriage
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000026', 'term': 'Abortion, Habitual'}], 'ancestors': [{'id': 'D000022', 'term': 'Abortion, Spontaneous'}, {'id': 'D011248', 'term': 'Pregnancy Complications'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 175}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2024-04-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-03', 'completionDateStruct': {'date': '2027-01-31', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-03-18', 'studyFirstSubmitDate': '2023-11-30', 'studyFirstSubmitQcDate': '2023-11-30', 'lastUpdatePostDateStruct': {'date': '2025-03-20', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-12-08', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-01-31', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'the incidence of chronic endometritis in local women with unexplained recurrent miscarriage', 'timeFrame': '31 January 2027', 'description': 'the incidence of chronic endometritis in local women with unexplained recurrent miscarriage'}], 'secondaryOutcomes': [{'measure': 'Investigate the spectrum of endometrial microorganisms associated with chronic endometritis in this population', 'timeFrame': '31 January 2027', 'description': 'Investigate the spectrum of endometrial microorganisms associated with chronic endometritis in this population'}, {'measure': 'Assess the clinical pregnancy outcomes between cured CE group and non-CE group', 'timeFrame': '31 January 2027', 'description': 'Assess the clinical pregnancy outcomes in both cured CE group and non-CE group'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['chronic endometritis', 'antibiotics', 'unexplained recurrent miscarriage women'], 'conditions': ['Recurrent Miscarriage']}, 'descriptionModule': {'briefSummary': 'The aim of the study is to estimate the incidence of CE, evaluate the endometrial microorganism of CE, and investigate the therapeutic benefits of antibiotics for women with unexplained recurrent miscarriage and CE.', 'detailedDescription': 'Eligible women, based on the inclusion and exclusion criteria, will be recruited from the miscarriage clinic in the Prince of Wales Hospital. Endometrial sampling (ES) will alternatively be conducted during mid-luteal phase. In natural cycles, all the subjects will have a daily urine test from day 9 of the menstrual cycle to identify the Luteinizing Hormone (LH) surge. The ES will be obtained precisely 7 days after LH surge. Endometrial samples will be obtained using a Pipelle sampler as an outpatient procedure. The endometrium will be divided into three aliquots. One will be fixed in 4% formalin for 24 hours, routinely processed and embedded in paraffin wax. One will be investigated by microbial culture for infectious agents and one will be sequenced to reveal the endometrial microbiota.\n\nCE will be diagnosed either by the presence of plasma cells and changes in endometrial stromal cells identified using HE and IHC, or by the finding of infectious agents using microbial culture. The selection of antibiotics will be based on the type of infectious agents or empirical, doxycycline 100mg BD po. for 14 days, for women with negative microbial culture. Endometrial biopsy will be repeated at the same time point after antibiotic treatment for women with CE. For persistent subjects with negative culturing, ciprofloxacin 500mg, BD po., and metronidazole 400mg TDS po. for 14 days will be used. The treatment will be repeated for three courses at maximum for women with persistent CE according to their willingness.'}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT'], 'maximumAge': '45 Years', 'minimumAge': '20 Years', 'genderBased': True, 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Subjects will be identified and recruited from the miscarriage clinic by clinicians and research assistants and research nurse.', 'genderDescription': 'Please kindly see the inclusion criteria. The endometrics sampling is only done for female patients.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Women with a history of 2 or more consecutive miscarriages before 24 weeks of gestation\n* Women aged 20-45 years old\n\nExclusion Criteria:\n\n* Uncorrected uterine anomalies, such as the septate or bicornuate uterus, fibroids (submucous/intramural)\n* Untreated hydrosalpinx\n* Antiphospholipid syndrome\n* Known clinical autoimmune disease\n* Undergoing immunotherapy\n* Abnormal thyroid function\n* Abnormal karyotyping of couples\n* Known immunodeficiency pathologies such as diabetes or HIV\n* Currently taking other antibiotics or other trial medications or TCM;\n* Currently or previously involved in other clinical trials with medication intake;\n* Those with active pelvic inflammatory disease or suspicion of infection etc.'}, 'identificationModule': {'nctId': 'NCT06163092', 'briefTitle': 'Chronic Endometritis and Benefits of Antibiotics in Women With Recurrent Miscarriage', 'organization': {'class': 'OTHER', 'fullName': 'Chinese University of Hong Kong'}, 'officialTitle': 'The Prevalence of Chronic Endometritis and Therapeutic Benefits of Antibiotics in Women With Unexplained Recurrent Miscarriage', 'orgStudyIdInfo': {'id': '2023.526'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Observational study', 'description': 'Women with recurrent miscarriage would be invited to do endometrial sampling (ES) procedure. The ES will be conducted precisely 7 days after LH surge. It will be obtained using a Pipelle sampler as an outpatient procedure.'}], 'interventions': [{'type': 'OTHER', 'description': 'If the CE is high, antibiotics will be given to the patients as usual practice in hospitals.', 'armGroupLabels': ['Observational study']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Hong Kong', 'status': 'RECRUITING', 'country': 'Hong Kong', 'contacts': [{'name': 'PUI WAH JACQUELINE CHUNG, MBBS', 'role': 'CONTACT', 'email': 'jacquelinechung@cuhk.edu.hk', 'phone': '+852 35051537'}, {'name': 'Stacey Wong, Bsc', 'role': 'CONTACT', 'email': 'staceywong@cuhk.edu.hk', 'phone': '+852 35051764'}, {'name': 'PUI WAH JACQUELINE CHUNG, MBBS', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'TAO ZHANG, MBBS', 'role': 'SUB_INVESTIGATOR'}, {'name': 'JING XI JOSHUA LI, MBBS', 'role': 'SUB_INVESTIGATOR'}, {'name': 'WAI YIN NG, MBBS', 'role': 'SUB_INVESTIGATOR'}], 'facility': 'The Chinese University of Hong Kong', 'geoPoint': {'lat': 22.27832, 'lon': 114.17469}}], 'centralContacts': [{'name': 'Stacey Wong, BSc', 'role': 'CONTACT', 'email': 'staceywong@cuhk.edu.hk', 'phone': '35051764'}, {'name': 'Jacqueline Pui Wah Chung, MBBS', 'role': 'CONTACT', 'email': 'jacquelinechung@cuhk.edu.hk', 'phone': '35051764'}], 'overallOfficials': [{'name': 'Jacqueline Pui Wah Chung, MBBS', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Chinese University of Hong Kong'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Chinese University of Hong Kong', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Associate Professor', 'investigatorFullName': 'Chung Pui Wah Jacqueline', 'investigatorAffiliation': 'Chinese University of Hong Kong'}}}}